{"id":"fecal-microbial-transplantation","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal symptoms (abdominal pain, bloating, diarrhea)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Infection or bacteremia (rare)"}]},"_chembl":{"chemblId":"CHEMBL6068500","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT works by introducing diverse microbial populations from screened healthy donors into the patient's gastrointestinal tract, thereby restoring microbial diversity and function. This rebalancing of the microbiome can reduce pathogenic bacteria, restore beneficial metabolic functions, and modulate immune responses. The restored microbiota helps re-establish colonization resistance and normal gut barrier function.","oneSentence":"Fecal microbial transplantation (FMT) restores a healthy gut microbiome by transferring bacterial communities from a healthy donor to a patient with dysbiosis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:20.837Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (recurrent or refractory)"},{"name":"Inflammatory bowel disease (Crohn's disease, ulcerative colitis)"}]},"trialDetails":[{"nctId":"NCT04975217","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-14","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":10},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT03686202","phase":"PHASE2, PHASE3","title":"Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-11-30","conditions":"All Solid Tumors","enrollment":65},{"nctId":"NCT07374094","phase":"","title":"Clostridioides Difficile: Understanding Responses and Treatment Effects","status":"RECRUITING","sponsor":"Umeå University","startDate":"2026-01-26","conditions":"Clostridioides Difficile Infection","enrollment":200},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07348471","phase":"NA","title":"Fecal Microbiota Transplantation for the Treatment of ICU Delirium","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-01","conditions":"Delirium","enrollment":60},{"nctId":"NCT04444362","phase":"NA","title":"Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)","status":"ENROLLING_BY_INVITATION","sponsor":"Nanjing Medical University","startDate":"2025-01-01","conditions":"Cardiovascular Disease, Cardiopulmonary Bypass","enrollment":500},{"nctId":"NCT05831189","phase":"PHASE3","title":"A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2023-04-21","conditions":"Clostridium Difficile Infection Recurrence","enrollment":41},{"nctId":"NCT07265817","phase":"NA","title":"Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms","status":"NOT_YET_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2025-12-01","conditions":"Carbapenem-Resistant Enterobacteriaceae Colonization","enrollment":60},{"nctId":"NCT02269150","phase":"PHASE2","title":"Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-10","conditions":"Allogeneic Hematopoietic Stem Cell","enrollment":59},{"nctId":"NCT07223606","phase":"","title":"Fecal Microbiota Transplant for Neuroblastoma in a Single Patient","status":"NO_LONGER_AVAILABLE","sponsor":"ProgenaBiome","startDate":"","conditions":"Neuroblastoma, Neuroblastoma (NB), Neuroblastoma (NBL)","enrollment":""},{"nctId":"NCT07172191","phase":"NA","title":"Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies","status":"ENROLLING_BY_INVITATION","sponsor":"Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases","startDate":"2025-10-01","conditions":"Malignant Hematologic Neoplasm","enrollment":100},{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT07083882","phase":"PHASE2","title":"Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-09","conditions":"Type 1 Diabetes Mellitis, Type 1 Diabetes (T1D), Fecal Microbiota Therapy (FMT)","enrollment":110},{"nctId":"NCT04691284","phase":"NA","title":"Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation","status":"RECRUITING","sponsor":"National Cancer Institute, Slovakia","startDate":"2021-03-01","conditions":"Hematologic Neoplasms","enrollment":100},{"nctId":"NCT06992453","phase":"NA","title":"Multi-omics Dissection of Gut Microbiome Engraftment During FMT","status":"NOT_YET_RECRUITING","sponsor":"Catholic University of the Sacred Heart","startDate":"2025-06-01","conditions":"Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC), Metabolic Syndrome (MetS)","enrollment":90},{"nctId":"NCT03796598","phase":"PHASE1, PHASE2","title":"FMT in Cirrhosis and Hepatic Encephalopathy","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-07-29","conditions":"Cirrhosis, Hepatic Encephalopathy","enrollment":60},{"nctId":"NCT06355583","phase":"PHASE2","title":"Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-05-01","conditions":"Acute Lymphoblastic Leukaemia, Acute Leukemia of Ambiguous Lineage, Chronic Myeloid Leukemia","enrollment":50},{"nctId":"NCT06895252","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis (UC)","enrollment":220},{"nctId":"NCT06890650","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohn Disease","enrollment":168},{"nctId":"NCT06890637","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohns Disease","enrollment":168},{"nctId":"NCT06906445","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis","enrollment":220},{"nctId":"NCT06268990","phase":"NA","title":"FMT in Obesity: RYGB vs. LEAN vs. Autologous FMT","status":"RECRUITING","sponsor":"Wiebke Kristin Fenske","startDate":"2023-01-01","conditions":"Morbid Obesity, Metabolic Syndrome, Diabetes","enrollment":30},{"nctId":"NCT03772899","phase":"PHASE1","title":"Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2019-03-27","conditions":"Melanoma","enrollment":20},{"nctId":"NCT03838601","phase":"NA","title":"Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-07-02","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":30},{"nctId":"NCT05182775","phase":"NA","title":"A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy","status":"COMPLETED","sponsor":"Shanxi Provincial People's Hospital","startDate":"2022-01-01","conditions":"IgA Nephropathy","enrollment":15},{"nctId":"NCT05516472","phase":"EARLY_PHASE1","title":"Fecal Microbiota Transplantation in Kidney Stone Patients","status":"RECRUITING","sponsor":"Joshua Stern","startDate":"2024-10-10","conditions":"Kidney Stones","enrollment":36},{"nctId":"NCT04970446","phase":"PHASE1, PHASE2","title":"Microbial Restoration in Inflammatory Bowel Diseases","status":"RECRUITING","sponsor":"St Vincent's Hospital Melbourne","startDate":"2022-05-01","conditions":"Fecal Microbiota Transplantation, Crohn Disease, Inflammatory Bowel Diseases","enrollment":120},{"nctId":"NCT05006430","phase":"PHASE1, PHASE2","title":"Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis","status":"RECRUITING","sponsor":"Prasun Kumar Jalal","startDate":"2023-01-21","conditions":"Alcoholic Hepatitis","enrollment":50},{"nctId":"NCT06393400","phase":"PHASE1","title":"CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)","status":"RECRUITING","sponsor":"John Lenehan","startDate":"2025-01-08","conditions":"Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma","enrollment":20},{"nctId":"NCT06697119","phase":"NA","title":"Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-03-09","conditions":"Irritable Bowel Disease","enrollment":44},{"nctId":"NCT04096443","phase":"EARLY_PHASE1","title":"Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Griffin Hospital","startDate":"2019-10-28","conditions":"Multiple Sclerosis","enrollment":9},{"nctId":"NCT04410003","phase":"PHASE1","title":"Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2020-06-02","conditions":"Atherosclerosis, Intestinal Microbiome","enrollment":100},{"nctId":"NCT05790356","phase":"NA","title":"Fecal Microbial Transplantation for Rheumatoid Arthritis Trial","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-08-01","conditions":"Arthritis, Arthritis, Rheumatoid, Fecal Microbiota Transplantation","enrollment":30},{"nctId":"NCT04951583","phase":"PHASE2","title":"Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-11-16","conditions":"Non Small Cell Lung Cancer Metastatic, Advanced Melanoma","enrollment":45},{"nctId":"NCT03931941","phase":"PHASE3","title":"Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)","status":"COMPLETED","sponsor":"Rebiotix Inc.","startDate":"2019-07-30","conditions":"Clostridium Difficile Infection, Infection, Communicable Diseases","enrollment":793},{"nctId":"NCT03244644","phase":"PHASE3","title":"Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)","status":"COMPLETED","sponsor":"Rebiotix Inc.","startDate":"2017-07-31","conditions":"Clostridium Difficile Infection (CDI)","enrollment":320},{"nctId":"NCT05329636","phase":"PHASE1, PHASE2","title":"Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy","status":"RECRUITING","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-09-26","conditions":"Helicobacter Pylori Infection","enrollment":30},{"nctId":"NCT04201821","phase":"PHASE1, PHASE2","title":"Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2021-01-14","conditions":"Fecal Incontinence","enrollment":10},{"nctId":"NCT06424041","phase":"PHASE2","title":"Fecal Microbiome Transplantation From Healthy Donors to Individuals With Fibromyalgia","status":"ENROLLING_BY_INVITATION","sponsor":"Rambam Health Care Campus","startDate":"2024-03-11","conditions":"Fibromyalgia","enrollment":100},{"nctId":"NCT05578196","phase":"NA","title":"Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.","status":"RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2022-09-04","conditions":"Sepsis, Infections","enrollment":110},{"nctId":"NCT06250413","phase":"NA","title":"Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics","status":"NOT_YET_RECRUITING","sponsor":"Otto Helve","startDate":"2024-02","conditions":"Microbial Colonization, Antibiotic Side Effect","enrollment":40},{"nctId":"NCT04173208","phase":"NA","title":"Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study","status":"UNKNOWN","sponsor":"Helsinki University Central Hospital","startDate":"2019-11-10","conditions":"Fecal Microbiota Transplantation, Cesarean Section, Affecting Fetus or Newborn, Intestinal Microbiome","enrollment":90},{"nctId":"NCT05873348","phase":"NA","title":"A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2023-01-10","conditions":"Fecal Microbiota Transplantation, COVID-19 Infection","enrollment":30},{"nctId":"NCT04388930","phase":"","title":"The Microbiota in Kidney Donation and Transplantation","status":"UNKNOWN","sponsor":"Royal Free Hospital NHS Foundation Trust","startDate":"2020-03-01","conditions":"Kidney Diseases, Kidney Transplant Failure and Rejection, Urinary Tract Infections","enrollment":130},{"nctId":"NCT02291523","phase":"PHASE1","title":"The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis","status":"UNKNOWN","sponsor":"Children's Hospital Los Angeles","startDate":"2016-11-01","conditions":"Ulcerative Colitis","enrollment":101},{"nctId":"NCT03426826","phase":"PHASE1","title":"The Gut-Brain Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2019-08-15","conditions":"Autism Spectrum Disorder (ASD), Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT06050148","phase":"PHASE2, PHASE3","title":"Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2023-08-01","conditions":"Recurrent Urinary Tract Infection","enrollment":100},{"nctId":"NCT03557749","phase":"","title":"Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2018-09-21","conditions":"Immune and Microbial Reconstitution, Systemic Viral Infection, Acute-graft-versus-host Disease","enrollment":210},{"nctId":"NCT02326636","phase":"","title":"Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2014-04","conditions":"Clostridium Difficile Infection","enrollment":37},{"nctId":"NCT05430269","phase":"NA","title":"Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients","status":"UNKNOWN","sponsor":"Charles University, Czech Republic","startDate":"2023-02-09","conditions":"Diarrhea Caused by Drug, Clostridium Difficile Infections","enrollment":36},{"nctId":"NCT02403089","phase":"","title":"Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-03","conditions":"Term and Preterm Neonates (24-41 Weeks Gestational Age), Hematopoietic Stem Cell Transplant Recipient Children","enrollment":300},{"nctId":"NCT04150549","phase":"PHASE2","title":"FMT for MS Patients","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-06","conditions":"Multiple Sclerosis","enrollment":34},{"nctId":"NCT04758806","phase":"PHASE3","title":"Fecal Microbial Transplantation in Severe Alcoholic Hepatitis","status":"UNKNOWN","sponsor":"F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica","startDate":"2018-04-01","conditions":"Alcoholic Hepatitis","enrollment":50},{"nctId":"NCT04283968","phase":"PHASE3","title":"Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-10-15","conditions":"Atopic Dermatitis","enrollment":50},{"nctId":"NCT05461833","phase":"NA","title":"FMT for Post-infectious IBS","status":"COMPLETED","sponsor":"Bogomolets National Medical University","startDate":"2020-09-01","conditions":"Irritable Bowel Syndrome","enrollment":59},{"nctId":"NCT05352269","phase":"PHASE1","title":"Safety and Tolerability of FMT Capsules in Healthy Volunteers","status":"UNKNOWN","sponsor":"Shenzhen Xbiome Biotech Co., Ltd.","startDate":"2022-04-21","conditions":"Acute-graft-versus-host Disease","enrollment":36},{"nctId":"NCT03548051","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-01-11","conditions":"Clostridial Infection, Dysbiosis, Probiotic Therapy","enrollment":10},{"nctId":"NCT03268213","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2013-11","conditions":"Clostridium Difficile Infection, Ulcerative Colitis, Indeterminate Colitis","enrollment":12},{"nctId":"NCT03267238","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplantation in Patients With Crohn's Disease","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2017-06-16","conditions":"Crohn Disease","enrollment":9},{"nctId":"NCT03477916","phase":"PHASE2","title":"Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2018-04-09","conditions":"Obesity, Metabolic Syndrome","enrollment":68},{"nctId":"NCT03720392","phase":"PHASE2","title":"Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)","status":"TERMINATED","sponsor":"Zachariah Michael DeFilipp","startDate":"2019-01-15","conditions":"Allogeneic Hematopoietic Cell Transplantation (HCT)","enrollment":8},{"nctId":"NCT02272868","phase":"PHASE1, PHASE2","title":"Fecal Microbial Transplant in Pediatric Crohn's Disease","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"2015-01","conditions":"Crohn's Disease","enrollment":7},{"nctId":"NCT04521075","phase":"PHASE1, PHASE2","title":"A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC","status":"UNKNOWN","sponsor":"Ella Therapeutics Ltd","startDate":"2020-11-01","conditions":"Melanoma Stage IV, Unresectable Melanoma, NSCLC Stage IV","enrollment":42},{"nctId":"NCT03061097","phase":"PHASE1","title":"Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization","status":"COMPLETED","sponsor":"Microbiome Health Research Institute","startDate":"2017-07-10","conditions":"Antibiotic Resistant Strain","enrollment":7},{"nctId":"NCT04861649","phase":"NA","title":"Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition","status":"UNKNOWN","sponsor":"Shanghai Asclepius Meditec Inc.","startDate":"2021-03-09","conditions":"Fecal Microbiota Transplantation","enrollment":40},{"nctId":"NCT03087097","phase":"PHASE1","title":"Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Patients in the Rehabilitative Phase of Malnutrition","status":"TERMINATED","sponsor":"Microbiome Health Research Institute","startDate":"2019-04-11","conditions":"Severe Acute Malnutrition, Moderate Acute Malnutrition","enrollment":5},{"nctId":"NCT04613037","phase":"EARLY_PHASE1","title":"Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2017-11-01","conditions":"Atopic Dermatitis","enrollment":15},{"nctId":"NCT02865616","phase":"PHASE1","title":"MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)","status":"COMPLETED","sponsor":"NuBiyota","startDate":"2017-10-27","conditions":"Clostridium Difficile Infection","enrollment":19},{"nctId":"NCT03876327","phase":"PHASE2, PHASE3","title":"Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease","status":"COMPLETED","sponsor":"Soroka University Medical Center","startDate":"2015-08-19","conditions":"Parkinson Disease","enrollment":10},{"nctId":"NCT03416751","phase":"PHASE1","title":"Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis","status":"COMPLETED","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2018-02-01","conditions":"Cirrhosis, Alcohol Abuse","enrollment":20},{"nctId":"NCT03926286","phase":"PHASE1","title":"Fecal Microbial Transplant (FMT) for Sjogrens Syndrome","status":"COMPLETED","sponsor":"University of Miami","startDate":"2019-04-15","conditions":"Sjogren's Syndrome","enrollment":10},{"nctId":"NCT03727321","phase":"PHASE2","title":"FMT and Fiber in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2018-07-01","conditions":"Obesity, Metabolic Syndrome","enrollment":68},{"nctId":"NCT04336319","phase":"PHASE2","title":"Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-07-05","conditions":"Ileal Pouch Anal Anastomosis","enrollment":40},{"nctId":"NCT04328922","phase":"NA","title":"Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-07-03","conditions":"Crohn Disease, Microbial Substitution","enrollment":80},{"nctId":"NCT03492502","phase":"NA","title":"Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease","status":"WITHDRAWN","sponsor":"Rambam Health Care Campus","startDate":"2019-08-01","conditions":"Fecal Microbiota Transplantation in Graft vs. Host Disease","enrollment":""},{"nctId":"NCT04264975","phase":"NA","title":"Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2018-06-04","conditions":"Solid Carcinoma","enrollment":60},{"nctId":"NCT03183869","phase":"PHASE2","title":"Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2017-08-24","conditions":"Autoimmune Diseases, Relapsing Multiple Sclerosis","enrollment":14},{"nctId":"NCT02423967","phase":"PHASE1","title":"Fresh Versus Frozen Stool for Fecal Transplant in Children","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2015-04","conditions":"Clostridium Difficile","enrollment":28},{"nctId":"NCT02487238","phase":"PHASE1","title":"Pediatric FEcal Microbiota Transplant for Ulcerative Colitis","status":"COMPLETED","sponsor":"McMaster Children's Hospital","startDate":"2015-11","conditions":"Inflammatory Bowel Disease, Ulcerative Colitis","enrollment":35},{"nctId":"NCT02496390","phase":"PHASE1, PHASE2","title":"Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2016-06","conditions":"Diabetes Mellitus, Non-alcoholic Fatty Liver Disease","enrollment":21},{"nctId":"NCT02390726","phase":"EARLY_PHASE1","title":"Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2015-12","conditions":"Ulcerative Colitis, Active Moderate","enrollment":20},{"nctId":"NCT03333291","phase":"NA","title":"Fecal Transplantation in Patients With IBS","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2016-10-01","conditions":"IBS - Irritable Bowel Syndrome","enrollment":14},{"nctId":"NCT01847170","phase":"PHASE1","title":"Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2013-05","conditions":"Crohn's Disease","enrollment":22},{"nctId":"NCT02154867","phase":"PHASE2","title":"Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2014-12","conditions":"Irritable Bowel Syndrome","enrollment":90},{"nctId":"NCT01896635","phase":"PHASE2","title":"Faecal Microbiota Transplantation in Ulcerative Colitis","status":"COMPLETED","sponsor":"The University of New South Wales","startDate":"2013-11","conditions":"Ulcerative Colitis, Inflammatory Bowel Disease","enrollment":81},{"nctId":"NCT01972334","phase":"PHASE2","title":"Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection","status":"COMPLETED","sponsor":"MemorialCare Health System","startDate":"2013-10","conditions":"Clostridium Difficile Colitis","enrollment":9},{"nctId":"NCT02391012","phase":"PHASE1","title":"Fecal Transplantation for Inflammatory Bowel Disease","status":"TERMINATED","sponsor":"Meir Medical Center","startDate":"2015-04","conditions":"Inflammatory Bowel Disease","enrollment":9},{"nctId":"NCT02133651","phase":"","title":"Mucosal Versus Fecal Microbiota in FMT","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-04","conditions":"Clostridium Difficile","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":280,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FMT","Fecal Transplant","Stool transplant"],"phase":"phase_3","status":"active","brandName":"Fecal Microbial Transplantation","genericName":"Fecal Microbial Transplantation","companyName":"ProgenaBiome","companyId":"progenabiome","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fecal Microbial Transplantation (FMT) is being studied as a potential treatment for various conditions, including steroid-refractory Graft-versus-host Disease, according to a clinical trial (NCT07602751) conducted by Bambino Gesù Hospital and Research Institute. The conditions studied in this trial include Acute Graft Versus Host Disease in Intestine, among others, and FMT is being compared to a placebo.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":4,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}